Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Dicyclohexylcarbodiimide | HCID 10868 | — |
| Reactant | Vancomycin monohydrochloride | HCID 6420023 | — |
| Reactant | N-hydroxybenzothiazole | HCID 15176256 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Vancomycin | HCID 14969 | — |
Reaction Steps
Triethylamine (2 mL) was added to a DMF solution (30 mL) containing vancomycin hydrochloride (1 g), biotinlyated amine (biotin-hexanediamine-aminocaproic acid, 0.4 g), and N-hydroxybenzothiazole (200 mg). After addition of 1,3-dicyclohexylcarbodiimide (1.48 g), the mixture was heated at 50° C. for 10 h and then left at ambient temperature for overnight. The solvent was evaporated to dryness. The residue was eluted on a silica gel column firstly using ethyl acetate:methanol:dichloromethane:ammonium hydroxide (6:6:2:1.2 by volume), and then 5-7% by volume of ammonium hydroxide in methanol. The ammonium-methanol fractions containing vancomycin bidentate was pooled, and the solvent was evaporated to give the solid vancomycin bidentate (yield: 0.16 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06800608B2 |
|---|
| Source dataset | uspto-grants-2004_10 |
|---|
| ORD ID | ord-0602082d8bd340fe8e1ebfba263caed2 |
|---|
| Source note | uspto-grants-2004_10 |
|---|